Literature DB >> 21849424

Tear production and ocular surface changes in experimental dry eye after elimination of desiccating stress.

Kyung-Chul Yoon1, Kyu-Youn Ahn, Won Choi, Zhengri Li, Ji-Suk Choi, Seung-Hyun Lee, Soo-Hyun Park.   

Abstract

PURPOSE: To investigate the severity and duration of desiccating stress-induced dry eye disease between mice with and without a genetic predisposition to spontaneous autoimmunity.
METHODS: Experimental dry eye was induced in 12- to 16-week-old wild-type C57BL/6 and autoimmune NOD.B10.H2(b) mice by subcutaneous injection of scopolamine with exposure to an air draft for 10 days. Tear volume and corneal smoothness were measured at baseline, 5 and 10 days after desiccating stress, and 3, 7, 14, and 28 days after the removal of desiccating stress. Periodic acid-Schiff staining and immunohistochemistry were performed to evaluate the densities of conjunctival goblet cells and CD4(+) T cells in each group. Interleukin (IL)-1β and IL-6 concentrations in conjunctival tissues were measured by multiplex immunobead assay.
RESULTS: Signs of experimental dry eye were noted at 5 and 10 days after desiccating stress in both strains. After the removal of desiccating stress, in C57BL/6 mice, tear production and corneal smoothness improved at 3 and 7 days, respectively, and conjunctival goblet cells and CD4(+) T-cell densities and cytokine levels returned to baseline levels at 14 days. In contrast, in NOD.B10.H2(b) mice, none of the parameters recovered to baseline levels during a period of 28 days after the removal of desiccating stress.
CONCLUSIONS: After the removal of desiccating stress in experimental dry eye, tear volume and ocular surface parameters recovered within 2 weeks in C57BL/6 mice, whereas they remained unchanged in NOD mice. In contrast to autoimmune mice, experimental dry eye can be reversed after the elimination of desiccating stress in nonsusceptible mice.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21849424     DOI: 10.1167/iovs.11-7231

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  31 in total

1.  Suppression of Th1-Mediated Keratoconjunctivitis Sicca by Lifitegrast.

Authors:  Rodrigo Guimaraes de Souza; Zhiyuan Yu; Michael E Stern; Stephen C Pflugfelder; Cintia S de Paiva
Journal:  J Ocul Pharmacol Ther       Date:  2018-06-29       Impact factor: 2.671

2.  Treg-recruiting microspheres prevent inflammation in a murine model of dry eye disease.

Authors:  Michelle L Ratay; Andrew J Glowacki; Stephen C Balmert; Abhinav P Acharya; Julia Polat; Lawrence P Andrews; Morgan V Fedorchak; Joel S Schuman; Dario A A Vignali; Steven R Little
Journal:  J Control Release       Date:  2017-05-10       Impact factor: 9.776

3.  Desiccating stress-induced disruption of ocular surface immune tolerance drives dry eye disease.

Authors:  M Guzmán; I Keitelman; F Sabbione; A S Trevani; M N Giordano; J G Galletti
Journal:  Clin Exp Immunol       Date:  2016-02-15       Impact factor: 4.330

Review 4.  Transgenic dry eye mouse models: powerful tools to study dry eye disease.

Authors:  Dan-Yi Qin; Li-Xiang Wang; Ying-Ping Deng
Journal:  Int J Ophthalmol       Date:  2022-04-18       Impact factor: 1.779

5.  Manifestation of meibomian gland dysfunction in patients with Sjögren's syndrome, non-Sjögren's dry eye, and non-dry eye controls.

Authors:  Yeon Soo Kang; Hyo Seok Lee; Ying Li; Won Choi; Kyung Chul Yoon
Journal:  Int Ophthalmol       Date:  2017-05-31       Impact factor: 2.031

6.  Lacrimal Gland Inflammation Deregulates Extracellular Matrix Remodeling and Alters Molecular Signature of Epithelial Stem/Progenitor Cells.

Authors:  Takeshi Umazume; William M Thomas; Sabrina Campbell; Hema Aluri; Suharika Thotakura; Driss Zoukhri; Helen P Makarenkova
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

Review 7.  Sjögren syndrome: what and where are we looking for?

Authors:  Cintia S de Paiva; Eduardo Melani Rocha
Journal:  Curr Opin Ophthalmol       Date:  2015-11       Impact factor: 3.761

8.  Anti-inflammatory effects of paeoniflorin from Paeonia lactiflora Pall. on human corneal epithelial cells and a mouse model of dry eye disease.

Authors:  Mincong Zhao; Li Liu; Yating Zheng; Guangrong Liu; Biao Che; Penghui Li; Huixiong Chen; Changzhi Dong; Li Lin; Zhiyun Du
Journal:  RSC Adv       Date:  2019-04-29       Impact factor: 4.036

9.  A cerium oxide loaded glycol chitosan nano-system for the treatment of dry eye disease.

Authors:  Fan Yu; Min Zheng; Alice Yang Zhang; Zongchao Han
Journal:  J Control Release       Date:  2019-10-24       Impact factor: 9.776

10.  Changes of Ocular Surface and the Inflammatory Response in a Rabbit Model of Short-Term Exposure Keratopathy.

Authors:  Chun-Ting Lai; Wei-Chieng Yao; Szu-Yuan Lin; Hsin-Yu Liu; Huai-Wen Chang; Fung-Rong Hu; Wei-Li Chen
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.